CEO Summary: CMS and CDC are weighing updates to CLIA that could reshape oversight of laboratory developed tests, AI tools, molecular testing, and clinical laboratory compliance. A healthcare attorney notes that CLIA modernization is needed, but future changes could also bring added costs for labs. Clinical laboratories could face new requirements covering laboratory developed tests […]
To access this post, you must purchase The Dark Report.